Use of multiplex allele-specific polymerase chain reaction (MAS-PCR) to detect multidrug-resistant tuberculosis in Panama

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Chia, Bing Shao ^a   Lanzas, Fedora ^b   Rifat, Dalin ^a   Herrera, Aubrey ^a   Kim, Elizabeth Y ^c   Sailer, Christine ^a   Torres Chavolla, Edith ^a   Narayanaswamy, Purvaja ^d   Einarsson, Viktor ^d   Bravo, Jaime ^b   Pascale, Juan M ^b   Ioerger, Thomas R ^d   Sacchettini, James C ^d   Karakousis, Petros C ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ICGES   (Panama)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; KATG PROTEIN; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CODON; DNA SEQUENCE; GENE; GENE FREQUENCY; GENE SEQUENCE; INHA GENE; KATG GENE; MABA GENE; MOLECULAR PATHOLOGY; MULTIDRUG RESISTANT TUBERCULOSIS; MULTIPLEX ALLELE SPECIFIC POLYMERASE CHAIN REACTION; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PANAMA; POINT MUTATION; PROMOTER REGION; RPOB GENE; SENSITIVITY AND SPECIFICITY;

ALLELES; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; ISONIAZID; MOLECULAR DIAGNOSTIC TECHNIQUES; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOBACTERIUM TUBERCULOSIS; OPERON; OXIDOREDUCTASES; PANAMA; POINT MUTATION; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84863666387     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040456     Document Type: Article

References (34)

1. World Health Organization (2011) WHO report 2011: global tuberculosis control. pp. WHO/HTM/TB/2011.16.
2. O'Brien RJ, Nunn PP, (2001) The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps. Am J Respir Crit Care Med 163: 1055-1058.
3. Aristimuno L, Armengol R, Cebollada A, Espana M, Guilarte A, et al. (2006) Molecular characterisation of Mycobacterium tuberculosis isolates in the First National Survey of Anti-tuberculosis Drug Resistance from Venezuela. BMC Microbiol 6: 90.
4. Dalla Costa ER, Ribeiro MO, Silva MS, Arnold LS, Rostirolla DC, et al. (2009) Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. BMC Microbiol 9: 39.
5. Hofling CC, Pavan EM, Giampaglia CM, Ferrazoli L, Aily DC, et al. (2005) Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil. Int J Tuberc Lung Dis 9: 87-93.
6. US Census Bureau. The hispanic population: 2010. 29 February (2012) C2010BR-04. Accessed Available at:http://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf.
7. Cain KP, Haley CA, Armstrong LR, Garman KN, Wells CD, et al. (2007) Tuberculosis among foreign-born persons in the United States: achieving tuberculosis elimination. Am J Respir Crit Care Med 175: 75-79.
8. Sandgren A, Strong M, Muthukrishnan P, Weiner BK, Church GM, et al. (2009) Tuberculosis drug resistance mutation database. PLoS Med 6: e2.
9. Zhang Y, Heym B, Allen B, Young D, Cole S, (1992) The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358: 591-593.
10. Karakousis PC, (2009) Mechanisms of Action and Resistance of Antimycobacterial Agents. In: Mayers D, editors. pp. 271-291 editor. Antimicrobial Drug Resistance. New York: Humana Press. pp.
11. Yang Z, Durmaz R, Yang D, Gunal S, Zhang L, et al. (2005) Simultaneous detection of isoniazid, rifampin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay. Diagn Microbiol Infect Dis 53: 201-208.
12. Afanas'ev MV, Ikryannikova LN, Il'ina EN, Sidorenko SV, Kuz'min AV, et al. (2007) Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation. J Antimicrob Chemother 59: 1057-1064.
13. Caws M, Duy PM, Tho DQ, Lan NT, Hoa DV, et al. (2006) Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam. J Clin Microbiol 44: 2333-2337.
14. Gegia M, Mdivani N, Mendes RE, Li H, Akhalaia M, et al. (2008) Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutations. Antimicrob Agents Chemother 52: 725-729.
15. Mokrousov I, Narvskaya O, Otten T, Limeschenko E, Steklova L, et al. (2002) High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob Agents Chemother 46: 1417-1424.
16. Park YK, Shin S, Ryu S, Cho SN, Koh WJ, et al. (2005) Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea. J Microbiol Methods 63: 165-172.
17. Qian L, Abe C, Lin TP, Yu MC, Cho SN, et al. (2002) rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries. J Clin Microbiol 40: 1091-1094.
18. Ramaswamy SV, Dou SJ, Rendon A, Yang Z, Cave MD, et al. (2004) Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiol 53: 107-113.
19. Van Rie A, Warren R, Mshanga I, Jordaan AM, van der Spuy GD, et al. (2001) Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol 39: 636-641.
20. Yue J, Shi W, Xie J, Li Y, Zeng E, et al. (2003) Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China. J Clin Microbiol 41: 2209-2212.
21. Kapur V, Li LL, Iordanescu S, Hamrick MR, Wanger A, et al. (1994) Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol 32: 1095-1098.
22. Cavusoglu C, Hilmioglu S, Guneri S, Bilgic A, (2002) Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol 40: 4435-4438.
23. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, et al. (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363: 1005-1015.
24. DeVito JA, Morris S, (2003) Exploring the structure and function of the mycobacterial KatG protein using trans-dominant mutants. Antimicrob Agents Chemother 47: 188-195.
25. Ramaswamy SV, Reich R, Dou SJ, Jasperse L, Pan X, et al. (2003) Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 47: 1241-1250.
26. Gagneux S, Burgos MV, DeRiemer K, Encisco A, Munoz S, et al. (2006) Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog 2: e61.
27. Payton M, Auty R, Delgoda R, Everett M, Sim E, (1999) Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance. J Bacteriol 181: 1343-1347.
28. Sandy J, Mushtaq A, Kawamura A, Sinclair J, Sim E, et al. (2002) The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis-an enzyme which inactivates the anti-tubercular drug, isoniazid. J Mol Biol 318: 1071-1083.
29. Pan American Health Organization. Manual for the bacteriological diagnosis of tuberculosis (Spanish version). Accessed http://www.paho.org/Spanish/AD/DPC/CD/tb-labs-cultivo.pdf.
30. Technical proceedings for the bacteriological diagnostic of Tuberculosis. Panama National TB Control Program (Supported by: National Ministry of Health, Social Security, Gorgas Institute, Central Reference Laboratory of Public Health) Republic of Panama.
31. Ioerger TR, Koo S, No EG, Chen X, Larsen MH, et al. (2009) Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa. PLoS One 4: e7778.
32. Ramaswamy S, Musser JM, (1998) Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 79: 3-29.
33. Slayden RA, Barry CE 3rd (2000) The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis. Microbes Infect 2: 659-669.
34. Tho DQ, Ha DT, Duy PM, Lan NT, Hoa DV, et al. (2008) Comparison of MAS-PCR and GenoType MTBDR assay for the detection of rifampicin-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 12: 1306-1312.